Fariba Behbod

4.7k total citations
62 papers, 3.1k citations indexed

About

Fariba Behbod is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Fariba Behbod has authored 62 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 36 papers in Molecular Biology and 22 papers in Cancer Research. Recurrent topics in Fariba Behbod's work include Cancer Cells and Metastasis (31 papers), Cytokine Signaling Pathways and Interactions (10 papers) and Epigenetics and DNA Methylation (9 papers). Fariba Behbod is often cited by papers focused on Cancer Cells and Metastasis (31 papers), Cytokine Signaling Pathways and Interactions (10 papers) and Epigenetics and DNA Methylation (9 papers). Fariba Behbod collaborates with scholars based in United States, Netherlands and France. Fariba Behbod's co-authors include Jeffrey M. Rosen, Wendy A. Woodward, Maria P. Alfaro, Thomas A. Buchholz, Daniel Medina, Frances Kittrell, Robert A. Kirken, Barry D. Kahan, David G. Edwards and Anna Tsimelzon and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Fariba Behbod

60 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fariba Behbod United States 26 1.8k 1.6k 715 505 226 62 3.1k
Carla P. Martins United Kingdom 19 1.4k 0.8× 2.0k 1.3× 611 0.9× 531 1.1× 252 1.1× 25 3.1k
Yiyu Zou United States 23 1.3k 0.7× 2.5k 1.6× 666 0.9× 616 1.2× 289 1.3× 51 3.6k
Jinyang Li United States 25 985 0.6× 1.3k 0.8× 610 0.9× 470 0.9× 258 1.1× 51 2.4k
Masahiro Hitomi United States 30 1.2k 0.7× 2.1k 1.3× 632 0.9× 256 0.5× 188 0.8× 65 3.0k
Adriana Eramo Italy 32 1.9k 1.1× 2.5k 1.6× 1.1k 1.5× 634 1.3× 460 2.0× 49 4.1k
Xuanmao Jiao United States 30 1.3k 0.8× 1.8k 1.2× 655 0.9× 540 1.1× 251 1.1× 58 3.0k
Thomas Bogenrieder Germany 25 1.2k 0.7× 1.2k 0.8× 536 0.7× 371 0.7× 342 1.5× 63 2.6k
Matthew G. Annis Canada 27 835 0.5× 2.0k 1.3× 827 1.2× 484 1.0× 223 1.0× 44 3.0k
Soner Altiok United States 27 1.3k 0.7× 2.1k 1.3× 646 0.9× 758 1.5× 433 1.9× 60 3.5k

Countries citing papers authored by Fariba Behbod

Since Specialization
Citations

This map shows the geographic impact of Fariba Behbod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fariba Behbod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fariba Behbod more than expected).

Fields of papers citing papers by Fariba Behbod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fariba Behbod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fariba Behbod. The network helps show where Fariba Behbod may publish in the future.

Co-authorship network of co-authors of Fariba Behbod

This figure shows the co-authorship network connecting the top 25 collaborators of Fariba Behbod. A scholar is included among the top collaborators of Fariba Behbod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fariba Behbod. Fariba Behbod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dogra, Samrita, Fariba Behbod, Chao Xu, et al.. (2025). Preferential release of microRNAs via extracellular vesicles is associated with ductal carcinoma in situ to invasive breast cancer progression. Cancer Letters. 625. 217794–217794. 1 indexed citations
2.
Behbod, Fariba, Jennifer Chen, & Alastair M. Thompson. (2023). Human Ductal Carcinoma In Situ: Advances and Future Perspectives. Cold Spring Harbor Perspectives in Medicine. 13(10). a041319–a041319. 3 indexed citations
3.
Fang, Wei Bin, Fariba Behbod, Jennifer R. Knapp, et al.. (2023). Transcriptome analysis reveals differences in cell cycle, growth and migration related genes that distinguish fibroblasts derived from pre-invasive and invasive breast cancer. Frontiers in Oncology. 13. 1130911–1130911. 5 indexed citations
4.
Behbod, Fariba, et al.. (2023). Mouse intraductal modeling of primary ductal carcinoma in situ. STAR Protocols. 4(3). 102526–102526. 1 indexed citations
5.
Rodríguez-Tirado, Carolina, Nupura Kale, María J. Carlini, et al.. (2022). NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells. Cancer Research. 82(12). 2313–2326. 20 indexed citations
6.
Ku, Amy T., Adelaide I.J. Young, Ahmed Atef Ibrahim, et al.. (2022). Short-term PI3K Inhibition Prevents Breast Cancer in Preclinical Models. Cancer Prevention Research. 16(2). 65–73. 4 indexed citations
7.
Fang, Wei Bin, Garth Fraga, Li‐Ching Huang, et al.. (2021). Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression. Scientific Reports. 11(1). 8708–8708. 24 indexed citations
8.
Ghosh, Arnab, Sandipto Sarkar, Snigdha Banerjee, et al.. (2018). MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis. PLoS ONE. 13(5). e0198143–e0198143. 23 indexed citations
9.
Behbod, Fariba, Angélica M. Gomes, & Heather L. Machado. (2018). Modeling Human Ductal Carcinoma In Situ in the Mouse. Journal of Mammary Gland Biology and Neoplasia. 23(4). 269–278. 15 indexed citations
10.
Sarkar, Tapasree Roy, et al.. (2018). ATM-dependent activation of SIM2s regulates homologous recombination and epithelial–mesenchymal transition. Oncogene. 38(14). 2611–2626. 18 indexed citations
11.
Valdez, Kelli E., Hong Yan, Sandra L. Grimm, et al.. (2017). NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast Cancer. Cancer Research. 77(14). 3802–3813. 10 indexed citations
12.
Brummer, Gage, Qingting Hu, Wei Bin Fang, et al.. (2017). Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms. Molecular Cancer Research. 16(2). 296–308. 44 indexed citations
13.
Behbod, Fariba & María dM Vivanco. (2015). Side Population. Methods in molecular biology. 1293. 73–81. 11 indexed citations
14.
Sameni, Mansoureh, Neha Aggarwal, Omar E. Franco, et al.. (2015). Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration. BMC Cancer. 15(1). 584–584. 85 indexed citations
15.
Stecklein, Shane R., et al.. (2012). Emerging Functions of microRNA-146a/b in Development and Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 17(1). 79–87. 15 indexed citations
16.
Yeh, Hung‐Wen, Byron Gajewski, Purna Mukhopadhyay, & Fariba Behbod. (2012). The Zero-Truncated Poisson With Right Censoring: An Application to Translational Breast Cancer Research. Statistics in Biopharmaceutical Research. 4(3). 252–263. 3 indexed citations
17.
Bussard, Karen M., Corinne A. Boulanger, Frances Kittrell, et al.. (2010). Immortalized, premalignant epithelial cell populations contain long-lived, label-retaining cells that asymmetrically divide and retain their template DNA. Breast Cancer Research. 12(5). R86–R86. 15 indexed citations
18.
Zhang, Mei, Fariba Behbod, Rachel L. Atkinson, et al.. (2008). Identification of Tumor-Initiating Cells in a p53-Null Mouse Model of Breast Cancer. Cancer Research. 68(12). 4674–4682. 260 indexed citations
19.
Behbod, Fariba, Rebecca Erwin-Cohen, Mouer Wang, et al.. (2001). Concomitant Inhibition of Janus Kinase 3 and Calcineurin-Dependent Signaling Pathways Synergistically Prolongs the Survival of Rat Heart Allografts. The Journal of Immunology. 166(6). 3724–3732. 51 indexed citations
20.
Stepkowski, S M, Zsuzsanna Nagy, Fariba Behbod, et al.. (2001). PNU156804 inhibits Jak3 tyrosine kinase and rat heart allograft rejection. Transplantation Proceedings. 33(7-8). 3272–3273. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla P. Martins Breakdown of academic impact, for papers by Yiyu Zou Breakdown of academic impact, for papers by Jinyang Li Breakdown of academic impact, for papers by Masahiro Hitomi Breakdown of academic impact, for papers by Adriana Eramo Breakdown of academic impact, for papers by Xuanmao Jiao Breakdown of academic impact, for papers by Thomas Bogenrieder Breakdown of academic impact, for papers by Matthew G. Annis Breakdown of academic impact, for papers by Soner Altiok
Rankless by CCL
2026